The News
Richard M. Brodsky Foundation - PRESIDENT'S VOLUNTEER SERVICE AWARD
- Tuesday, 30 August 2011 10:38
- Last Updated on Thursday, 13 October 2011 18:21
The Richard M. Brodsky Foundation has partnered with the White House to become a Certifying Organization for the President's Volunteer Service Award, a national program recognizing Americans who have demonstrated a sustained commitment to volunteer service. This National Award is issued by the President's Council on Service and Civic Participation, to help foster and encourage a culture of volunteer service and civic participation among Americans. We encourage everyone to get involved and to encourage your family, friends and neighbors to create opportunities to change our local and global community. Together, we can make difference one life at a time. Please contact us for more information about partnering with the Richard M. Brodsky Foundation.
Richard Brodsky's Journey of Hope
- Monday, 29 August 2011 06:15
- Last Updated on Tuesday, 26 September 2023 05:39
UPDATE: Richard Brodsky's Journey of Hope has just been updated as of September 2020 and 8 brand new pages have been added and many other pages have been updated, (Download: Journey of Hope). Be an armchair participant and/or sponsor (Sponsor Package)
Mike Polansky, President of the Greater Long Island Running Club, comments: “There is no harder working team of race directors on Long Island than Richard and Jodi Brodsky.” Join Richard on his Journey through his journey that will be sure to raise hope and enthusiasm for the Foundations mission. READ AN EXCERPT FROM THE BOOK
NEW Research claims HIV could be Reduced to Minor Infection
- Saturday, 07 July 2007 04:54
- Last Updated on Thursday, 13 October 2011 18:21
Exciting new research reveals that a potent new vaccine may help to reduce HIV to no more than a minor chronic infection, according to Spanish researchers. ABC News states that the vaccine—known as MVA-B—could reduce HIV to the same category as the herpes virus.
Professor Mariano Esteban of the Spanish Superior Scientific Research council tested MVA-B on 24 healthy patients, and found that 90 percent of them developed an immunological response to the virus. Of those, 85 percent still had the response after one year of receiving the vaccine.
As ABC News states: “This is a big step in HIV/AIDS research, which still has a long way to go before a cure is found.” MVA-B contains four HIV genes that activate two types of white blood cells designed to attack and anihilate HIV-infected cells. Almost 75% of the test subjects developed HIV-specific antibodies after the vaccine in order to protect against the virus.
We are excited to see what additional research Esteban and his team will provide in the future.